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Faye S. Silverstein, MDCM, Jennifer Simpson, BA, and Kevin E. Gordon, MD 
In adult brain, during insulin-induced hypoglycemia, striatal extracellular flwid concentrations of the excitatory amino 
acids glutamate and aspartate rise markedly (fourfold to tenfold). In this study, we used in vivo microdialysis to 
determine if insulin-induced hypoglycemia altered striatal amino acid efflLur in similar fashion in the immature brain. 
Microdialysis probes were inserted into the right striaturn of rats on po5tnatal day 7. After a 2-hour recovery period, in 
each animal a 30-minute baseline sample was obtained. Then insulin (0.6 Flkg, intraperitoneal injection) was adminis- 
tered (n = 6) and dialysate sampling was continued over the next 210 minutes (terminal blood glucose level < 5 mg/ 
dl). Untreated control rats (n = 6) were sampled over the same time interval. After pre-column derivatization with 
o-phthaldialdehyde, dialysate samples were assayed by high-pressure liquid chromatography with electrochemical 
detection to measure their amino acid content; eight amino acids (glutamate, aspartate, taurine, glutamine, alanine, 
serine, glycine, and asparagine) were consistently detected. In controls, amino acid efflux did not change over 4 hours. 
In hypoglycemic animals, glutamate efflux increased (peak 238 * 85% of baseline, p = 0.02, repeated measures 
analysis of variance {ANOVA)), glutamine efflux declined (to 44 f 5% of baqeline,p = 0.002, ANOVA), and taurine 
efflux increased (up to 310 k 120% of baseline; p < 0.06, ANOVA). In contrast with 7- to 12-fold increases in aspartate 
efflux reported in adult striatum, aspartate efflux increased only slightly (to 174 ? 69% of baseline; not significant). In 
immature rodent brain, overall trends in striatal amino acid efflux during hypoglycemia are similar to patterns 
reported in adult animals; however, there are major differences in the timing, duration, and magnitude of these 
responses. 
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Recent studies, both in vivo and in vitro, suggest that 
the excitatory amino acid neurotransmitters glutamate 
and aspartate contribute to the pathogenesis of hypo- 
glycemia-induced selective neuronal necrosis [ 1-41. In 
mature experimental animals, striatal and hippocampal 
extracellular fluid (ECF) concentrations of aspartate 
and glutamate rise markedly during hypoglycemia [ 1, 
23, and both deafferentation [4] and treatment with 
excitatory amino acid antagonists [ 5 ]  attenuate hypo- 
glycemia-induced neuronal damage. In murine cortical 
cell cultures deprived of glucose, the extent of neuro- 
nal degeneration is reduced by addition of specific glu- 
tamate antagonists to the medium [6].  Recent studies 
demonstrated that the immature brain is susceptible to 
excitatory amino acid-mediated (“excitotoxic”) neuro- 
nal damage; the glutamate analogues N-methyl-D- 
aspartate and quisqualic acid are potent neurotoxins in 
postnatal day (PND) 7 rats [7,8]. It is thus conceivable 
that elevated synaptic concentrations of endogenous 
glutamate or aspartate could be neurotoxic at this de- 
velopmental stage. 
Systemic hypoglycemia is readily induced by injec- 
tion of insulin and verified by measurement of declin- 
ing blood glucose concentrations. The immature brain 
may differ in its response to both insulin and hypogly- 
cemia from the mature brain; the immature brain is 
often considered relatively resistant to the detrimental 
effects of hypoglycemia because of more efficient utili- 
zation of alternate substrates (fatty acids and lactate) as 
well as lower metabolic demands [9]. 
In vivo microdialysis is a new method for sampling 
the ECF content of specific chemicals of interest in 
defined brain regions [lo]. A microdialysis probe is 
inserted into a designated brain region, the probe is 
continuously perfused with a physiological solution, 
and the concentrations of compounds of interest are 
measured in dialysate samples. In brain, ECF levels of 
neurotransmitters are believed to reflect regional syn- 
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aptic concentrations. Several reports have character- 
ized amino acid efflux in striatum and hippocampus of 
mature animals, and have delineated characteristic 
changes in their efflux during hypoglycemia [l, 21 and 
cerebral ischemia El 1, 121. 
We recently developed a method for in vivo striatal 
microdialysis in PND 7, Sprague-Dawley rats [13]. 
The goals of this study were to use this method to 
measure striatal ECF neurotransmitter amino acid 
efflux in PND 7 rats and to determine the impact of 
severe hypoglycemia on striatal ECF efflux of these 
compounds. 
Materials and Methods 
Microdia&s Protocol 
Microdialysis probes were implanted into the striatum of 
PND 7, Sprague-Dawley rat pups, according to previously 
described methods [ 131. Subsequent histological examina- 
tion of Nissl-stained, horizontal brain sections was done to 
verify placement of the probe within the midstriatum; only 
data from pups with accurate probe placement were evalu- 
ated (about two-thirds of animals). 
The probes had a concentric design, and 2-mm dialyzing 
tip (outside diameter, 250 pm; molecular weight cutoff, 
6,000; Spectra-Por, Spectrum Medical, Los Angeles, CA). 
The microdialysis probe's efficiency of recovery for each 
amino acid was determined in vitro before insertion and the 
probe was then glued to a rigid plastic mounting system that 
could be readily affixed to the skull surface [13]. 
In each animal, a midline scalp flap was excised under 
ether anesthesia. One to 2 hours later, pups were reanes- 
thetized and placed in a stereotaxic frame. A cranial flap was 
excised (2.5 mm lateral, 1 mm posterior to the bregma) and 
the probe was lowered and glued into place. The probe tip 
extended 3 to 5 mm from the skull surface. Probes were 
perfused with filtered modified Ringer's solution (147 mM 
sodium chloride, 4 mM potassium chloride, 3.4 mM calcium 
chloride; pH 7.2) at 1.5 pl/min using a microinfusion pump 
(CMA 100, Bioanalytical Systems, Inc, West Lafayette, IN). 
At the end of each experiment, pups were killed by decapita- 
tion. Brains were quickly removed and placed in formalin. 
Blood glucose levels were measured by Dextrostix (Miles, 
Elkhart, IN) on blood obtained from the carotid arteries. 
Animals were allowed to recover for 2 hours in plastic 
containers, partially submerged in a warm water bath; the 
duration of the stabilization period was based on results of 
earlier studies of catecholamine metabolites. Then collection 
of samples was initiated; eght  sequential 30-minute samples 
were collected on ice from each animal. Surface body tem- 
perature was monitored with an electronic thermometer and 
was maintained at 35.5"C. The microdialysis protocol was 
approved by the University of Michigan Committee on Use 
and Care of Animals. 
To induce hypoglycemia, after baseline sampling, pups re- 
ceived an intraperitoneal injection of regular insulin (0.6 p/ 
kg). This dose initially produced hyperactivity, and predict- 
ably resulted in clinical coma 1 to 2 hours later. The majority 
of pups survived over the next 3.5 hours while the dialysis 
sampling continued (20% mortality in insulin-in jected pups 
during this period). However, no pups treated with the same 
dose of insulin survived beyond 24 hours. 
Sixteen additional animals received the same dose of insu- 
lin and were killed by decapitation 0.5 to 4.0 hours later. 
Blood glucose levels were measured to determine the tem- 
poral pattern and severity of hypoglycemia (assayed by Dex- 
trostix and glucometer on blood obtained from carotid ar- 
teries). Control blood glucose levels ranged from 100 to 120 
mg/dl. In the first hour after insulin administration, glucose 
values were typically 30 to 40 mg/dl; at 2 hours after injec- 
tion, values were 20 mgidl or less; and at 3 to 4 hours, values 
were consistently less than 5 mgidl. This was the lowest dose 
of insulin that reproducibly elicited profound hypoglycemia. 
Chemical Analysis 
All samples were frozen and were subsequently thawed for 
analysis by high-performance liquid chromatography with 
electrochemical detection. A precolumn derivatization pro- 
cedure was used (modified from [14]). Each sample (45 p1) 
was mixed with 22.5 pl of a solution containing 27 mg 
o-phthaldialdehyde in 2 ml of 100 mM borax with 20 pl of 
mercaptoethanol (pH 9.5) for 30 seconds. The internal stan- 
dard homoserine (22.5 pl) was included with each sample to 
correct for variations in the efficiency of derivatization. Sam- 
ples (80 pI) were injected onto a C18 reverse phase column 
(5 p ODS); the mobile phase was a 0.1 M NaHzP04 (pH 
6.5) buffer with 35% methanol. A glassy carbon electrode 
connected to an electrochemical detector (Bioanalytical Sys- 
tems) was used (sensitivity, 20 nAmp; electrode potential, 
0.7 V versus silverisilver chloride); this relatively low sen- 
sitivity optimized the number of quantifiable peaks and mini- 
mized baseline noise. The detection thresholds for the assay 
were in the picomolar range. External standards containing 
nine amino acids, in the proportions and concentrations ex- 
pected in the dialysis samples, were assayed daily. In the 
dialysis samples, the consistently detected amino acids were 
glutamate, aspartate, glutamine, glycine, asparagine, taurine, 
serine, and alanine; gamma-aminobutyric acid (GAB A) was 
detected intermittently and chromatograms often included 
three or four consistent but unidentified peaks. 
Data Analysis 
Efflux values, corrected for efficiency of probe recovery, 
were expressed in pmollmin. In each animal, efflux values 
for each compound were expressed as percent of baseline 
efflux and group means (t standard error of mean [SEMI) 
for each sampling period were calculated. Descriptive statis- 
tics, analysis of variance (ANOVA) for repeated measures, 
and Fisher's exact test were performed using a microcompu- 
ter-based statistical package (Systat) [15]. 
Results 
Eight amino acids were consistently detected in striatal 
dialysate samples (Table). Baseline efflux values in con- 
trols ranged from 1.3 L 0.2 (aspartate) to 384 & 47 
pmol/min (glutamine) and values were similar in con- 
trols and experimental animals. To compare these re- 
sults with values derived from microdialysis studies in 
adult striatum, the baseline values were also used to 
calculate ECF amino acid concentrations. In PND 7 
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Baseline Striatal ECF Amino Acid EBux (pmollmin)" 
Control Experimental 
Glutamate 2.1 k 0.5 1.8 +- 0.5 
Taurine 13.3 7t 2.5 10.3 ? 1.2 
Asparagine 17.5 2 3.5 19.8 k 5.1 
Glutamine 384.0 * 47.0 453.0 * 21.0 
Serine 75.2 & 7.8 73.6 ? 4.2 
Alanine 40.2 * 4.5 29.2 ? 3.2 
Glycine 35.6 * 2.4 42.0 ? 9.8 
"Baseline values (mean f SEM) for each amino acid were the same 
in both groups. GABA was inconsistently detected in both groups. 
Aspartate 1.3 ? 0.2 1.8 f 0.3 
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Fig I .  Striatal glutamate 4Jux in control (n = 6) and hypogly- 
cemic (n = 6) postnatal duy (PND) 7 rats. A micvodialysis 
probe, perfused with modr5ed Ringefls solution at 1.5 kllmin, 
was inserted into the right striatum; after a 2-hour recoveq pe- 
riod, sampling was initiated. Each dialysis sample was collected 
over 30 minutes. In the experimental group, to induce hypogly- 
cemia, insulin 10.6 kIk@ was injected intraperitoneally afrer the 
baseline sample was completed (Time "0 rnin'y). In each animal, 
all values were expressed as percent baseline dflux and group 
means were calculated. In controls. striatal glutamate ejjflux de- 
clined slightly aver time. i n  hypoglycemic animals, e fpx  gradu- 
ally increased, peaking at 240% of baseline in the final sample, 
repeated measures ANOVA (p = 0.02) comparing sequential 
values in experimental and control animals. 
rats, the ECF concentration of glutamate (1.3 pM) was 
in the same range as striatal ECF glutamate concentra- 
tions reported in adult brain (0.92 p-M [2), 22 p M  
UGI). 
In controls, efflux values remained relatively stable 
over the 4-hour sampling period (Figs 1 through 4). In 
the experimental group, insulin was injected at the end 
of the baseline sampling period. In the next two sets of 
samples, obtained in the first hour after insulin injec- 
tion (expected blood glucose concentrations, 30 to 40 
I I 
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F i g  2. Striatal aspartate efflux in control (n = 6) and hypogly 
cemic in = 6)  postnatal day (PND) 7 rats (see F ig  I legend). 
Aspartate &flux was stable in controls. i n  hypoglycemic animals, 
although the trend appeared similar t o  the pattern of glutamate 
&$ux ( F i g  I ) ,  there was considerable variability and values did 
not differ from those in controls. 
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Fig 3. Striatal glutamine efJlux in control in = 6) and hypogly- 
cemic (n = 6) postnatal day (PND) 7 rats (see F i g  I legen4. I n  
the hypoglycemic animals, glutamine ej$Jux progressively declined. 
i n  the final sampling period, valuesfell t o  less than 30% of 
baseline (p = 0.005) repeated measures ANOVA. 
mg%), striatal amino acid efflux remained close to 
baseline values. In the next 2.5 hours, changes in 
amino acid efflux were detected in hypoglycemic ani- 
mals. 
In controls, striatal glutamate efflux declined slightly 
over time (see Fig 1). In contrast, in hypoglycemic 
animals, mean striatal glutamate efflux gradually in- 
creased, peaking at 240% of baseline in the final sam- 
ple (repeated measures ANOVA, p = 0.02, compar- 
ing sequential values in experimental and control 
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Fig  4. Striatal taurine &$ux in control (n  = 6) and bypogtyce- 
mzc (n = 6) postnatalddy (PND) 7 rats (see F i g  1 legend). Ef- 
#lux oabes were stable in  controls. In the bypogbcemic animals, 
taurine &jux began t o  rise in the second hour of hypoglycemia; 
d$ux values were most consistently elevated durzng tbejnal  sdm- 
pling period (196 * 209% of baseline) (p = 0.058, repeated 
measuw ANOVA, &hct of byfioglycmia over rime). 
animals). In S of 6 hypoglycemic animals, in at least 
one sampling period glutamate efflux rose to more 
than 150% of baseline (versus a peak of the same 
magnitude in only 1 of 6 controls, p = 0.002, Fisher’s 
exact test, two-tailed); however, the timing of the peak 
value varied among animals. Aspartate efflux was also 
stable in controls; in hypoglycemic animals, although 
the trend appeared similar to the pattern of glutamate 
efflux, no significant changes in aspartate efflux were 
detected (see Fig 2). 
In each sample glutamate-aspartate ratios were cal- 
culated. There were inter-animal and intra-animal dif- 
ferences in the glutamate-aspartate ratios both at 
baseline and subsequently in both control and experi- 
mental animals but no consistent patterns emerged. In 
hypoglycemic animals in the baseline samples, the 
glutamate-aspartate ratio was 0.94 * 0.16 (mean ? 
SEM) and in the final sample the corresponding value 
was 1.2 -+ 0.2. 
Figure 3 compares striatal glutamine efflux in the 
two groups. In controls, striatal glutamine efflux did 
not change, whereas in the hypoglycemic animals 
glutamine efflux progressively declined. Values began 
to fall in the second hour of hypoglycemia and in the 
final sampling period fell to less than 50% of baseline 
( p  = 0.005, repeated measures ANOVA). As- 
paragine efflux (data not shown) remained constant un- 
til the final sampling period when values declined to 67 
2 5% of baseline. 
Striatal taurine efflux was also stable in controls (see 
Fig 4). In the hypoglycemic animals, values fluctuated. 
Taurine efflux began to rise in the second hour of 
hypoglycemia; efflux values were most consistently 
elevated during the final sampling period (196 t 20% 
of baseline) ( p  = 0.058, repeated measures ANOVA, 
effect of hypoglycemia over time). 
A consistent small reduction in striatal glycine efflux 
was detected in hypoglycemic animals; efflux values 
declined to 76 k 10% of baseline in the final sampling 
period ( p  = 0.05, repeated measures ANOVA, effect 
of hypoglycemia over time). Alanine and serine efflux 
did not change during hypoglycemia (data not shown). 
GABA was not consistently detected in either control 
or hypoglycemic animals. 
Discussion 
These results demonstrate that striatal ECF efflux of 
excitatory amino acid neurotransmitters and related 
compounds can be monitored in PND 7 rats with in 
vivo microdialysis. In untreated controls, striatal amino 
acid efflux is remarkably stable over a 4-hour sampling 
period and striatal amino acid concentrations are in the 
same range as values reported in adult brain [1, 2, 161. 
In contrast, insulin-induced hypoglycemia markedly al- 
tered striatal amino acid efflux. 
In hypoglycemic animals glutamate efflux increased 
gradually; however, peak values were considerably 
lower than values reported in adult brain (fourfold in- 
crease in striatum [31). It was not feasible to measure 
blood or striatal ECF glucose levels during the mi- 
crodialysis experiments. However, based on blood glu- 
cose values from additional animals that had received 
the same dosage of insulin, it appeared that glutamate 
efflux did not increase until blood glucose values fell to 
less than 20 mg%. Glutamate efflux increased by at 
least 50% over baseline in at least one sampling period 
in 5 of 6 hypoglycemic animals (versus 1 of 6 controls); 
however, peak values were not sustained, which could 
reflect depletion of the releasable glutamate pool. Al- 
though the pattern of aspartate efflux during hypogly- 
cemia appeared to parallel the gradual rise in glutamate 
efflux, values were not significantly different from con- 
trols. This finding is in marked contradistinction with 
responses in adult brain in which 9-fold to 12-fold 
increases in striatal aspartate concentrations have been 
reported [3]. 
Increased glutamate efflux could reflect suppression 
of re-uptake, increased release, or increased transport 
into brain; our methods could not distinguish these 
mechanisms. Neuronal and glial re-uptake are energy- 
dependent processes that could fail during hypogly- 
cemia 1177. However, if re-uptake fdure accounted 
for glutamate accumulation during hypoglycemia, sus- 
tained elevations in glutamate efflux (rather than a 
transient peak) and corresponding increases in aspar- 
tate efflux, which shares a re-uptake pathway, would 
be expected. If hypoglycemia stimulated release of 
glutamate, its source could be a neurotransmitter or a 
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metabolic pool. In adult animals, a substantial propor- 
tion of striatal glutamate released in response to hypo- 
glycemia appears to be derived from a neurotransmit- 
ter pool IS]. However, results of a recent study, done 
in vitro in a synaptosomal preparation, suggested that 
with energy depletion a large component of glutamate 
release was calcium-independent and occurred by re- 
versal of a sodium-coupled uptake carrier [IS]. 
The most consistent change in amino acid efflux we 
observed was a marked, sustained reduction in gluta- 
mine efflux. Glutamine is a precursor for glutamate 
synthesis 1191. Thus, glutamine depletion may reflect 
increased glutamate release (together with failure of 
re-uptake) or its utilization as an alternate carbon 
group substrate for metabolic pathways {20]. Similar 
reductions in glutamine efflux have been observed in 
adult brain during hypoglycemia [2) and also accom- 
panying depolarization-evoked glutamate release 1 161. 
Taurine efflux increased during hypoglycemia, as has 
been described in adult brain 12 1). ECF concentrations 
of taurine, which may have a role in cerebral osmo- 
regulation {22}, also increase during perfusion of glu- 
tamate agonists into the adult hippocampus and this 
stimulation can be blocked by specific glutamate antag- 
onists {23}. As cell swelling is an early component in 
the neurotoxic effects of glutamate agonists 1241, in- 
creased taurine release could reflect an adaptive osmo- 
regulatory response. 
The developing brain may be less susceptible to hy- 
poglycemia-induced brain in jury than is the mature 
brain. Both lower cerebral metabolic rate (about 10% 
of adult values 1251) and greater use of lactate and 
ketone bodies as alternative substrates to glucose {9) 
may contribute to this difference. Yet, glucose to some 
extent remains essential for functioning of the central 
nervous system and profound insulin-induced hypogly- 
cemia is invariably associated with coma. Of note, 
doses of insulin which reproducibly elicit neuronal ne- 
crosis in striatum of mature animals do not result in 
similar damage in the immature brain [31 (Silverstein, 
unpublished observations). We could not determine if 
the large doses of insulin used in this experiment 
would result in irreversible neuronal damage, since no 
animals receiving this dosage survived beyond 24 
hours. 
The threshold for duration and severity of hypogly- 
cemia that elicits functional derangement and, possi- 
bly, irreversible neuronal damage in the developing 
brain has not been defined. As well, there may be 
regional and cellular differences in susceptibility to hy- 
poglycemia within the brain. Dialysate amino acid con- 
tent reflects averages of amino acid efflux from many 
neuronal populations, as well as glia, within the stri- 
atum. If the changes in amino acid efflux we observed 
coincide with functional disruption of striatal neurons, 
then the variability in efflux values in hypoglycemic 
animals may well reflect a wide range of susceptibility 
to hypoglycemia of specific neuronal populations in 
the developing striatum. 
The effects of inserting a dialysis probe and the limi- 
tations of the sampling method must also be consid- 
ered in interpreting our data. In mature animals inser- 
tion of a dialysis probe suppressed blood flow and 
glucose metabolism maximally in the first 2 hours after 
insertion 1261. Thus, sampling was initiated 2 hours 
after the insertions. The stability of efflux values in 
controls suggests that inserting the probe did not 
markedly disrupt amino acid efflux. A relatively long 
sampling period was used in order to maximize the 
number of detectable compounds; a limitation of this 
approach is that some biologically important fluctua- 
tions in efflux could be obscured. 
In clinical practice, the impact of neonatal hypogly- 
cemia on brain development has been difficult to de- 
lineate. The risk of adverse neurodevelopmental out- 
come is increased only in children with concomitant 
neonatal seizures 1271. It is unclear if the evolution of 
seizures is a marker for more severe hypoglycemia or 
an independent pathogenetic factor. We did not di- 
rectly address the issue of hypoglycemia-induced irre- 
versible brain injury; however, our data suggest that 
the pathophysiology of severe hypoglycemia in the de- 
veloping nervous system shares important neurochem- 
ical mechanisms with factors that contribute to neuro- 
nal damage in the mature brain. Although the extent 
of stimulation of excitatory amino acid efflux is less 
than that in mature brain and the timing and duration 
of altered amino acid efflux elicited by insulin-induced 
hypoglycemia in perinatal brain vary considerably 
more than in mature animals, overall, similar changes 
evolve. Since considerable experimental data indicate 
that the immature brain is susceptible to the excito- 
toxic properties of glutamate analogues {7, 81, hypo- 
glycemia-induced increases in ECF (and presumably 
synaptic) concentrations of glutamate may be neuro- 
toxic in the developing brain. 
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